Introduction
The pharmaceutical market is a complex and dynamic sector, influenced by various factors including regulatory changes, technological advancements, and market demand. This article focuses on the market analysis and price projections for the drug identified by the National Drug Code (NDC) 51645-0716, which is associated with PlusPharma Extra Strength PAIN RELIEVER, FEVER REDUCER 500 mg, a generic acetaminophen product.
Understanding the National Drug Code (NDC)
The NDC is a unique identifier assigned to each drug product by the FDA. It helps in tracking and managing drug products within the healthcare system. For NDC 51645-0716, the product is labeled and distributed by Gemini Pharmaceuticals, Inc. dba Plus Pharma[1].
Market Context
The US pharmaceutical market is projected to grow significantly, from $846.72 billion in 2022 to $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%[4].
Product Overview
- Generic Name: Acetaminophen
- Dosage Form: Tablet
- Route of Administration: Oral
- Active Ingredient Strength: 500 mg/1
- Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL[1].
Pricing Trends
Pricing in the pharmaceutical market is influenced by several factors, including production costs, regulatory approvals, and market competition.
Current Pricing
As of the latest available data, specific pricing for NDC 51645-0716 is not provided in the sources. However, pricing for over-the-counter (OTC) drugs like acetaminophen is generally stable due to high competition and generic availability.
Market Competition
The presence of generic drugs and biosimilars significantly impacts pricing. Nearly 37% of life sciences executives view competition from generic drugs and biosimilars as a top trend, which can drive prices down due to increased competition[3].
Regulatory Environment
The FDA's National Drug Code Directory contains information on all finished and unfinished drugs, including OTC products like acetaminophen. Regulatory changes and compliance requirements can affect pricing and availability[5].
Impact of Patent Expirations
The biopharma industry is facing a substantial loss of exclusivity due to expiring patents, which could lead to increased competition from generics and biosimilars. However, this is more relevant to patented drugs rather than OTC generics like acetaminophen[3].
Role of AI and Technological Advancements
The integration of technologies like AI is expected to boost operational efficiencies and drive innovations in the pharmaceutical industry. While this may not directly impact the pricing of existing OTC drugs, it could lead to more efficient production and distribution, potentially stabilizing or reducing costs[3].
Market Projections
Given the stable demand for pain relievers and fever reducers, the market for acetaminophen products is expected to remain steady. Here are some key projections:
Demand
The demand for OTC pain relievers and fever reducers is consistent due to their widespread use. This demand is likely to continue, driven by the need for effective and accessible healthcare products.
Pricing Stability
Due to the generic nature of acetaminophen and the competitive OTC market, prices for NDC 51645-0716 are expected to remain relatively stable. Any significant price fluctuations would likely be driven by changes in raw material costs or regulatory changes.
Competitive Landscape
The market for acetaminophen is highly competitive, with multiple manufacturers offering similar products. This competition helps maintain price stability and ensures that prices remain affordable for consumers.
Key Takeaways
- Stable Demand: The demand for OTC pain relievers and fever reducers is consistent.
- Pricing Stability: Prices for generic acetaminophen products are expected to remain stable due to high competition.
- Regulatory Compliance: Adherence to FDA regulations is crucial for maintaining market presence.
- Technological Advancements: While AI and other technologies may improve production efficiency, they are unlikely to significantly impact the pricing of existing OTC drugs.
FAQs
Q: What is the generic name of the drug associated with NDC 51645-0716?
A: The generic name is acetaminophen.
Q: Who is the labeler for the drug NDC 51645-0716?
A: The labeler is Gemini Pharmaceuticals, Inc. dba Plus Pharma.
Q: What is the dosage form and strength of the drug NDC 51645-0716?
A: The dosage form is a tablet, and the active ingredient strength is 500 mg/1.
Q: How does the competitive landscape affect the pricing of NDC 51645-0716?
A: The highly competitive nature of the OTC market helps maintain price stability and ensures that prices remain affordable for consumers.
Q: What role do technological advancements play in the pricing of NDC 51645-0716?
A: Technological advancements, such as AI, may improve production efficiency but are unlikely to significantly impact the pricing of existing OTC drugs like acetaminophen.
Sources
- FDA Report: NDC 51645-705 Oral Tablet PlusPharma Extra Strength PAIN RELIEVER, FEVER REDUCER 500 mg[1].
- DrugPatentWatch: Latest drug prices and trends for NDC 51672-1387[2].
- Deloitte Insights: 2025 life sciences outlook[3].
- GlobeNewswire: US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030[4].
- FDA: National Drug Code Directory[5].
